Biomay is a biotech company discovering and developing innovative allergy therapeutics. Biomay is a leader in the diagnostic and therapeutic use of recombinant allergens.
Biomay is a biotech company discovering and developing innovative allergy therapeutics. Biomay is a leader in the diagnostic and therapeutic use of recombinant allergens.
DLVR Therapeutics is developing an innovative, HDL-like Peptide-Phospholipid Scaffold (HPPS) nanoparticle delivery system, initially for RNAi therapeutics.